Login / Signup

Association of blood-based transcriptional risk scores with biomarkers for Alzheimer disease.

Young Ho ParkAngela HodgesAndrew SimmonsSimon LovestoneMichael W WeinerSangYun KimAndrew J SaykinKwangsik Nhonull null
Published in: Neurology. Genetics (2020)
The study is rated Class III because of the case control design and the risk of spectrum bias.
Keyphrases
  • case control
  • gene expression
  • mild cognitive impairment
  • transcription factor
  • heat shock